Submitted by Anonymous (not verified) on 7 November 2023 - 14:43
Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Leukemia, Myeloid, Acute, Date of authorisation: 24/10/2019, Revision: 5, Status: Authorised
Source: